Evidence map›Paper›PMID 36270985›Full record

ArticleCell death & disease2022

Diverse maturity-dependent and complementary anti-apoptotic brakes safeguard human iPSC-derived neurons from cell death.

Ruven Wilkens, Anne Hoffrichter, Karolina Kleinsimlinghaus, Bettina Bohl, Carolin Haag, Nadja Lehmann, Malin Schmidt, Elena Muñoz Perez-Vico, Julia Wangemann, Klara Franziska Rehder and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Oligodendrocyte Maturation Alters the Cell Death Mechanisms That Cause Demyelination.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Ruven WilkensDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.
Anne HoffrichterDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.ORCID 0000-0001-6009-7826
Karolina KleinsimlinghausDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.
Bettina BohlDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.ORCID 0000-0003-0373-7836
Carolin HaagDepartment of Neurophysiology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Nadja LehmannDepartment of Neurophysiology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.ORCID 0000-0003-4801-3057
Malin SchmidtDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.
Elena Muñoz Perez-VicoDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.
Julia WangemannDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.
Klara Franziska RehderDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.
Sandra HorschitzDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.
Georg KöhrDepartment of Neurophysiology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Julia LadewigDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.
Philipp KochDepartment of Translational Brain Research, Central Institute of Mental Health (ZI), University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany. Philipp.Koch@zi-mannheim.de.ORCID 0000-0003-3713-8786
German Cancer Research Center · DEHeidelberg University · DETechnische Hochschule Mannheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In humans, most neurons are born during embryonic development and have to persist throughout the entire lifespan of an individual. Thus, human neurons have to develop elaborate survival strategies to protect against accidental cell death. We set out to decipher the developmental adaptations resulting in neuronal resilience. We demonstrate that, during the time course of maturation, human neurons install a complex and complementary anti-apoptotic signaling network. This includes i.) a downregulation of central proteins of the intrinsic apoptosis pathway including several caspases, ii.) a shift in the ratio of pro- and anti-apoptotic BCL-2 family proteins, and iii.) an elaborate regulatory network resulting in upregulation of the inhibitor of apoptosis protein (IAP) XIAP. Together, these adaptations strongly increase the threshold for apoptosis initiation when confronted with a wide range of cellular stressors. Our results highlight how human neurons are endowed with complex and redundant preemptive strategies to protect against stress and cell death.

Indexed as

Induced Pluripotent Stem CellsApoptosisCaspasesCell DeathHumansInhibitor of Apoptosis ProteinsNeuronsProto-Oncogene Proteins c-bcl-2X-Linked Inhibitor of Apoptosis ProteinCaspasesInhibitor of Apoptosis ProteinsProto-Oncogene Proteins c-bcl-2X-Linked Inhibitor of Apoptosis Protein

Identifiers

PMID36270985
PMCPMC9587001
OpenAlexW4307090729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.